Isto Biologics Launches Influx Fibrant Allograft

Isto Biologics introduced Influx™ Fibrant, a line of functional constructs derived from 100% cortical allograft.

The Fibrant launch features the patented technology platform that Isto Biologics' recent acquisition of TheraCell brings to Isto's expanding portfolio of orthopedic allografts.

Isto's Fibrant Technology processes produce uniform...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us